This is consistent with published data showing a transient down-modulation of CD10 in the early phase of ALL treatment, with the changes being more pronounced in patients with a good response to prednisolone and a better prognosis of the disease.8,9,10,37. Here, MME is linked to acute lymphoblastic leukemia.